These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Baby doe redux? The Department of Health and Human Services and the Born-Alive Infants Protection Act of 2002: a cautionary note on normative neonatal practice. Sayeed SA Pediatrics; 2005 Oct; 116(4):e576-85. PubMed ID: 16199687 [TBL] [Abstract][Full Text] [Related]
4. Pediatric use of complementary and alternative medicine: legal, ethical, and clinical issues in decision-making. Gilmour J; Harrison C; Cohen MH; Vohra S Pediatrics; 2011 Nov; 128 Suppl 4():S149-54. PubMed ID: 22045856 [TBL] [Abstract][Full Text] [Related]
5. Ethics of complementary and alternative medicine use in children. Vohra S; Cohen MH Pediatr Clin North Am; 2007 Dec; 54(6):875-84; x. PubMed ID: 18061781 [TBL] [Abstract][Full Text] [Related]
6. Concluding comments: maximizing good patient care and minimizing potential liability when considering complementary and alternative medicine. Gilmour J; Harrison C; Vohra S Pediatrics; 2011 Nov; 128 Suppl 4():S206-12. PubMed ID: 22045865 [TBL] [Abstract][Full Text] [Related]
7. Informed consent: advising patients and parents about complementary and alternative medicine therapies. Gilmour J; Harrison C; Asadi L; Cohen MH; Vohra S Pediatrics; 2011 Nov; 128 Suppl 4():S187-92. PubMed ID: 22045862 [TBL] [Abstract][Full Text] [Related]
8. The use of complementary and alternative health care practices among children. Loman DG J Pediatr Health Care; 2003; 17(2):58-63. PubMed ID: 12665727 [TBL] [Abstract][Full Text] [Related]
9. Use of complementary and alternative medicine by children in the United States. Davis MP; Darden PM Arch Pediatr Adolesc Med; 2003 Apr; 157(4):393-6. PubMed ID: 12695237 [TBL] [Abstract][Full Text] [Related]
10. Latest CMDA ethics statements: alternative/complementary therapy; limits to parental authority in medical decision making; unionization. Christian Medical and Dental Associations Todays Christ Dr; 2002; 33(1):9. PubMed ID: 12599382 [No Abstract] [Full Text] [Related]
11. The adoption of complementary and alternative medicine by hospitals: a framework for decision making. Santa Ana CF J Healthc Manag; 2001; 46(4):250-60. PubMed ID: 11482243 [TBL] [Abstract][Full Text] [Related]
12. Complementary and alternative medicine use in children with type 1 diabetes: a pilot survey of parents. Miller JL; Binns HJ; Brickman WJ Explore (NY); 2008; 4(5):311-4. PubMed ID: 18775401 [TBL] [Abstract][Full Text] [Related]
13. Complementary and alternative treatment methods in children with cancer: A population-based retrospective survey on the prevalence of use in Germany. Laengler A; Spix C; Seifert G; Gottschling S; Graf N; Kaatsch P Eur J Cancer; 2008 Oct; 44(15):2233-40. PubMed ID: 18809313 [TBL] [Abstract][Full Text] [Related]
14. Children's visits to providers of complementary and alternative medicine in San Diego. Hughes SC; Wingard DL Ambul Pediatr; 2006; 6(5):293-6. PubMed ID: 17000420 [TBL] [Abstract][Full Text] [Related]
15. Hospitals and complementary and alternative medicine: managing responsibilities, risk, and potential liability. Gilmour J; Harrison C; Asadi L; Cohen MH; Vohra S Pediatrics; 2011 Nov; 128 Suppl 4():S193-9. PubMed ID: 22045863 [TBL] [Abstract][Full Text] [Related]
16. Complementary and alternative medical therapies used by children with cancer treated at an Italian pediatric oncology unit. Clerici CA; Veneroni L; Giacon B; Mariani L; Fossati-Bellani F Pediatr Blood Cancer; 2009 Oct; 53(4):599-604. PubMed ID: 19492321 [TBL] [Abstract][Full Text] [Related]
17. Legal and ethical issues relating to use of complementary therapies in pediatric hematology/oncology. Cohen MH J Pediatr Hematol Oncol; 2006 Mar; 28(3):190-3. PubMed ID: 16679948 [TBL] [Abstract][Full Text] [Related]
18. Exploration of the use of complementary and alternative medicine among Turkish children. Ozturk C; Karayagiz G J Clin Nurs; 2008 Oct; 17(19):2558-64. PubMed ID: 18808623 [TBL] [Abstract][Full Text] [Related]
19. New and lingering controversies in pediatric end-of-life care. Solomon MZ; Sellers DE; Heller KS; Dokken DL; Levetown M; Rushton C; Truog RD; Fleischman AR Pediatrics; 2005 Oct; 116(4):872-83. PubMed ID: 16199696 [TBL] [Abstract][Full Text] [Related]
20. Complementary and alternative medicine use in children with cancer and general and specialty pediatrics. Post-White J; Fitzgerald M; Hageness S; Sencer SF J Pediatr Oncol Nurs; 2009; 26(1):7-15. PubMed ID: 18936292 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]